| [1] |
Epstein DS,Mitra B,O’Reilly G, et al. Acute traumatic coagulopathy in the setting of isolated traumatic brain injury: a systematic review and meta-analysis[J]. Injury, 2014, 45(5): 819-824.
|
| [2] |
Mccully SP,Schreiber MA. Traumatic brain injury and its effect on coagulopathy[J]. Semin Thromb Hemost, 2013, 39(8): 896-901.
|
| [3] |
Maegele M,Schochl H,Cohen MJ. An update on the coagulopathy of trauma[J]. Shock, 2014, 41: 21-25.
|
| [4] |
Venugopal A. Disseminated intravascular coagulation[J]. Indian J Anaesth, 2014, 58(5): 603-608.
|
| [5] |
Figueroa SA,Merriman-Noesges K. Utility of thromboelastography in traumatic brain injury and the neuroscience intensive care unit[J]. J Neurosci Nurs, 2014, 46(2): 66-70.
|
| [6] |
Massaro AM,Doerfler S,Nawalinski K, et al. Thromboelastography defines late hypercoagulability after TBI: a pilot study[J]. Neurocrit Care, 2015, 22(1): 45-51.
|
| [7] |
Chapman MP,Moore EE,Ramos CR, et al. Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy[J]. J Trauma Acute Care Surg, 2013, 75(6): 961-967.
|
| [8] |
Chu AJ. Tissue factor, blood coagulation, and beyond: an overview[J]. Int J Inflam, 2011, 2011: 367284.
|
| [9] |
Kurland D,Hong C,Aarabi B, et al. Hemorrhagic progression of a contusion after traumatic brain injury: a review[J]. J Neurotrauma, 2012, 29(1): 19-31.
|
| [10] |
Palta S,Saroa R,Palta A. Overview of the coagulation system[J]. Indian J Anaesth, 2014, 58(5): 515-523.
|
| [11] |
Halpern CH,Reilly PM,Turtz AR, et al. Traumatic coagulopathy: the effect of brain injury[J]. J Neurotrauma, 2008, 25(8): 997-1001.
|
| [12] |
Lustenberger T,Talving P,Kobayashi L, et al. Time course of coagulopathy in isolated severe traumatic brain injury[J]. Injury, 2010, 41(9): 924-928.
|
| [13] |
Genet GF,Johansson PI,Meyer MA, et al. Trauma-induced coagulopathy: standard coagulation tests, biomarkers of coagulopathy, and endothelial damage in patients with traumatic brain injury[J]. J Neurotrauma, 2013, 30(4): 301-306.
|
| [14] |
Lee TH,Hampton DA,Diggs BS, et al. Traumatic brain injury is not associated with coagulopathy out of proportion to injury in other body regions[J]. J Trauma Acute Care Surg, 2014, 77(1): 67-72.
|
| [15] |
Heemskerk JW,Bevers EM,Lindhout T. Platelet activation and blood coagulation[J]. Thromb Haemost, 2002, 88(2): 186-193.
|
| [16] |
Wohlauer MV,Moore EE,Thomas S, et al. Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma[J]. J Am Coll Surg, 2012, 214(5): 739-746.
|
| [17] |
Kutcher ME,Redick BJ,Mccreery RC, et al. Characterization of platelet dysfunction after trauma[J]. J Trauma Acute Care Surg, 2012, 73(1): 13-19.
|
| [18] |
Davis PK,Musunuru H,Walsh M, et al. Platelet dysfunction is an early marker for traumatic brain injury-induced coagulopathy[J]. Neurocrit Care, 2012, 18(2): 201-208.
|
| [19] |
Castellino FJ,Chapman MP,Donahue DL, et al. Traumatic brain injury causes platelet adenosine diphosphate and arachidonic acid receptor inhibition independent of hemorrhagic shock in humans and rats[J]. J Trauma Acute Care Surg, 2014, 76(5): 1169-1176.
|
| [20] |
Donahue DL,Beck J,Fritz B, et al. Early platelet dysfunction in a rodent model of blunt traumatic brain injury reflects the acute traumatic coagulopathy found in humans[J]. J Neurotrauma, 2014, 31(4): 404-410.
|
| [21] |
Ploplis VA,Donahue DL,Sandoval-Cooper MJ, et al. Systemic platelet dysfunction is the result of local dysregulated coagulation and platelet activation in the brain in a rat model of isolated traumatic brain injury[J]. J Neurotrauma, 2014, 31(19): 1672-1675.
|
| [22] |
Maegele M. Coagulopathy after traumatic brain injury: incidence, pathogenesis, and treatment options[J]. Transfusion, 2013, 53: 28S-37S.
|
| [23] |
Davenport R. Pathogenesis of acute traumatic coagulopathy[J].Transfusion, 2013, 53: 23S-27S.
|
| [24] |
Cohen MJ,Brohi K,Ganter MT, et al. Early coagulopathy after traumatic brain injury: the role of hypoperfusion and the protein C pathway[J]. J Trauma, 2007, 63(6): 1254-1261.
|
| [25] |
Lustenberger T,Talving P,Kobayashi L, et al. Early coagulopathy after isolated severe traumatic brain injury: relationship with hypoperfusion challenged[J]. J Trauma, 2010, 69(6): 1410-1414.
|
| [26] |
Tian Y,Salsbery B,Wang M, et al. Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury[J]. Blood, 2015, 125(13): 2151-2159.
|
| [27] |
Alexiou GA,Lianos G,Fotakopoulos G, et al. Admission glucose and coagulopathy occurrence in patients with traumatic brain injury[J]. Brain Inj, 2014, 28(4): 438-441.
|
| [28] |
Tanaka KA,Mazzeffi M,Durila M. Role of prothrombin complex concentrate in perioperative coagulation therapy[J]. J Intensive Care, 2014, 2(1): 60.
|
| [29] |
Joseph B,Amini A,Friese RS, et al. Factor IX complex for the correction of traumatic coagulopathy[J]. J Trauma Acute Care Surg, 2012, 72(4): 828-833.
|
| [30] |
Sarode R,Milling TJ Jr,Refaai MA, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study[J]. Circulation, 2013, 128(11): 1234-1243.
|
| [31] |
Joseph B,Hadjizacharia P,Aziz H, et al. Prothrombin complex concentrate: an effective therapy in reversing the coagulopathy of traumatic brain injury[J]. J Trauma Acute Care Surg, 2013, 74(1): 248-253.
|
| [32] |
Joseph B,Aziz H,Pandit V, et al. Prothrombin complex concentrate use in coagulopathy of lethal brain injuries increases organ donation[J]. Am Surg, 2014, 80(4): 335-338.
|
| [33] |
Huynh TK,Costello JL,Rebuck JA. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy[J]. Pharmacotherapy, 2014, 34(3): 260-264.
|
| [34] |
Yuan Q,Wu X,Du ZY, et al. Low-dose recombinant factor VIIa for reversing coagulopathy in patients with isolated traumatic brain injury[J]. J Crit Care, 2015, 30(1): 116-120.
|
| [35] |
Brown CV,Foulkrod KH,Lopez D, et al. Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients[J]. J Trauma, 2010, 68(2): 348-352.
|
| [36] |
Kim B,Haque A,Arnaud FG, et al. Use of recombinant factor VIIa (rFVIIa) as pre-hospital treatment in a swine model of fluid percussion traumatic brain injury[J]. J Emerg Trauma Shock, 2014, 7(2): 102-111.
|
| [37] |
裴兵兵,栗超跃,路鑫,等.应用小剂量重组人凝血因子Ⅶa治疗单纯性颅脑创伤性凝血功能障碍[J].中华医学杂志, 2013, 93(23): 1780-1783.
|
| [38] |
Deloughery EP,Lenfesty B,Deloughery TG. The use of recombinant factor VIIa in warfarin patients with traumatic brain injury: a retrospective case-control study[J]. Blood Coagul Fibrinolysis, 2013, 24(3): 317-320.
|
| [39] |
Narayan RK,Maas AI,Marshall LF, et al. Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial[J]. Neurosurgery, 2008, 62(4): 776-788.
|
| [40] |
McQuay N Jr,Cipolla J,Franges EZ, et al. The use of recombinant activated factor VIIa in coagulopathic traumatic brain injuries requiring emergent craniotomy: is it beneficial[J]? J Neurosurg, 2009, 111(4): 666-671.
|
| [41] |
Shakur H,Roberts I,Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial[J]. Lancet, 2010, 376(9734).
|
| [42] |
Roberts I,Shakur H,Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial[J]. Lancet, 2011, 377(9771): 1096-1101.
|
| [43] |
Collaborators C. Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study)[J]. BMJ, 2011, 343(7): 369-369.
|
| [44] |
Perel P,Al-Shahi Salman R,Kawahara T, et al. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial[J]. Health Technol Assess, 2012, 16(13): 1-54.
|
| [45] |
Morrison JJ,Dubose JJ,Rasmussen TE, et al. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) sStudy[J]. Arch Surg, 2012, 147(2): 113-119.
|
| [46] |
Spahn DR,Bouillon B,Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline[J]. Crit Care, 2013, 17(2): R76.
|
| [47] |
Bachelani AM,Bautz JT,Sperry JL, et al. Assessment of platelet transfusion for reversal of aspirin after traumatic brain injury[J]. Surgery, 2011, 150(4): 836-843.
|
| [48] |
Brasel KJ,Vercruysse G,Spinella PC, et al. The association of blood component use ratios with the survival of massively transfused trauma patients with and without severe brain injury[J]. J Trauma, 2011, 71(2 Suppl 3): S343-352.
|
| [49] |
Anglin CO,Spence JS,Warner MA, et al. Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses[J]. J Neurosurg, 2013, 118(3): 676-686.
|
| [50] |
Briggs A,Gates JD,Kaufman RM, et al. Platelet dysfunction and platelet transfusion in traumatic brain injury[J]. J Surg Res, 2015, 193(2): 802-806.
|
| [51] |
Etemadrezaie H,Baharvahdat H,Shariati Z, et al. The effect of fresh frozen plasma in severe closed head injury[J]. Clin Neurol Neurosurg, 2007, 109(2): 166-171.
|
| [52] |
Peiniger S,Nienaber U,Lefering R, et al. Balanced massive transfusion ratios in multiple injury patients with traumatic brain injury[J]. Crit Care, 2011, 15(1): R68.
|